Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...

Two hundred miles from LA, an off-grid community with roots in Burning Man offers an unorthodox educational experience – is Mars College the future?

A drug that helped turn Novo Nordisk into Europe's most valuable company is about to lose its monopoly grip across much of the globe. Patent protections on semaglutide—sold as Ozempic for diabetes and ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...

Novartis NOVN0.89%increase; green up pointing triangle said it expected a key profitability metric to decline this year in large part due to increased competition in the U.S. from generic drug ...

Programming is the backbone of modern technology, and understanding a programming languages list is essential for developers, students, and tech enthusiasts. In 2026, Python leads AI and data science ...

Abstract: Generic Code Clone Detection (GCCD) is a tool that implemented distance measure as the method to detect code clones in the Java applications. This tool detects irrespective of code clone ...

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...